Skip to main content
Figure 1 | Reproductive Biology and Endocrinology

Figure 1

From: A large, multicentre, observational, post-marketing surveillance study of the 2:1 formulation of follitropin alfa and lutropin alfa in routine clinical practice for assisted reproductive technology

Figure 1

The reasons cited by physicians for prescribing the 2:1 formulation of follitropin alfa and lutropin alfa for 1834/2220 assisted reproductive technology (ART) cycles. (a) The number of reported pre-specified reasons (one or more reasons could be given; 1889 reasons were given for 1834 ART cycles); (b) Expansion of the pre-specified answer of ‘other’ (1315 responses of other were given in total; the six reasons cited most frequently are shown). Percentages are based on 1889 reasons. GnRH = gonadotrophin-releasing hormone; LH = luteinizing hormone.

Back to article page

Reproductive Biology and Endocrinology

ISSN: 1477-7827

Contact us